|
NavelbineDrug - Navelbine The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Vinorelbine Tartrate
Strength -
EQ 10MG BASE/ML
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020388
Product Number -
001
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Dec 23, 1994
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Navelbine
Navelbine Eq 10mg Base/ml Injectable; Injection
Vincristine Sulfate 1mg/ml Injectable; Injection Vincristine Sulfate 1mg/ml Injectable; Injection Vincristine Sulfate 1mg/ml Injectable; Injection Vincristine Sulfate 1mg/ml Injectable; Injection Vincristine Sulfate 1mg/vial Injectable; Injection Vincristine Sulfate 2mg/vial Injectable; Injection Vincristine Sulfate 5mg/vial Injectable; Injection Vincristine Sulfate Pfs 1mg/ml Injectable; Injection Vincristine Sulfate Pfs 1mg/ml Injectable; Injection NewDrugInformation |